PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors.PeptiMimesis will develop its pipeline against keytargets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

PEPTIMIMESIS

PEPTIMIMESIS' headquarters in Illkirch, France

PEPTIMIMESIS

Org chart

Teams

Offices

Similar companies